Utility of Follow-Up of 131I-MIBG Scintigraphy to Screen Pheochromocytoma

被引：0
作者：
Watanabe, Satoshi [1 ]
Kahara, Toshio [1 ]
Seto, Chikashi [2 ]
Uchiyama, Akio [3 ]
Abo, Hitoshi [4 ]
Ishikura, Kazuhide [1 ]
Nakajima, Ken-ichi [5 ]
Usuda, Rika [1 ]
机构：
[1] Toyama Prefectural Cent Hosp, Dept Internal Med, Toyama, Japan
[2] Toyama Prefectural Cent Hosp, Dept Urol, Toyama, Japan
[3] Toyama Prefectural Cent Hosp, Dept Clin Pathol, Toyama, Japan
[4] Toyama Prefectural Cent Hosp, Dept Radiol, Toyama, Japan
[5] Kanazawa Univ Hosp, Dept Nucl Med, Kanazawa, Ishikawa, Japan
来源：
INTERNAL MEDICINE | 2009年 / 48卷 / 18期
关键词：
I-131-MIBG scintigraphy; pheochromocytoma; paraganglioma; MIBG therapy;
D O I：
10.2169/internalmedicine.48.2507
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1711 / 1712
页数：2
相关论文
共 50 条
  • [31] Role of [68Ga]DOTANOC PET/computed tomography and [131I]MIBG scintigraphy in the management of patients with pheochromocytoma and paraganglioma: a prospective study
    Singh, Deepa
    Shukla, Jaya
    Walia, Rama
    Vatsa, Rakhee
    Paul, Nandini
    Chhabra, Anupriya
    Nahar, Uma
    Singh, Harmandeep
    Kumar, Rajender
    Bhansali, Anil
    Rai Mittal, Bhagwant
    NUCLEAR MEDICINE COMMUNICATIONS, 2020, 41 (10) : 1047 - 1059
  • [32] Draft guidelines regarding appropriate use of 131I-MIBG radiotherapy for neuroendocrine tumors: Guideline Drafting Committee for Radiotherapy with 131I-MIBG, Committee for Nuclear Oncology and Immunology, The Japanese Society of Nuclear Medicine
    Kinuya S.
    Yoshinaga K.
    Higuchi T.
    Jinguji M.
    Kurihara H.
    Kawamoto H.
    Annals of Nuclear Medicine, 2015, 29 (6) : 543 - 552
  • [33] 131-I MIBG therapy of malignant pheochromocytoma and paraganglioma tumours - a single-centre study
    Kotecka-Blicharz, Agnieszka
    Hasse-Lazar, Kornelia
    Handkiewicz-Junak, Daria
    Gawlik, Tomasz
    Pawlaczek, Agnieszka
    Oczko-Wojciechowska, Malgorzata
    Michalik, Barbara
    Szpak-Ulczok, Sylwia
    Krajewska, Jolanta
    Jurecka-Lubieniecka, Beata
    Jarzab, Barbara
    ENDOKRYNOLOGIA POLSKA, 2018, 69 (03) : 246 - 251
  • [34] Elevated 131I-MIBG activity in adrenocortical adenoma-what other imaging options do we have?
    Xia, Xiaotian
    Wang, Keshan
    Shao, Fuqiang
    Hu, Fan
    Hu, Shengqing
    Dai, Yu
    Zhang, Yongxue
    Lan, Xiaoli
    QUANTITATIVE IMAGING IN MEDICINE AND SURGERY, 2022, 12 (04) : 2591 - 2595
  • [35] Pheochromocytoma in internal medicine: distinctive features and place of 123I MIBG scintigraphy
    Noblet-Dick, M
    Grunenberger, F
    Brunot, B
    Jaeck, D
    Schlienger, JL
    REVUE DE MEDECINE INTERNE, 2003, 24 (06): : 358 - 365
  • [36] Bilateral pheochromocytoma: Clinical characteristics, treatment and longitudinal follow-up
    Kittah, Nana Esi
    Gruber, Lucinda M.
    Bancos, Irina
    Hamidi, Oksana
    Tamhane, Shrikant
    Iniguez-Ariza, Nicole
    Babovic-Vuksanovic, Dusica
    Thompson, Geoffrey B.
    Lteif, Aida
    Young, William F.
    Erickson, Dana
    CLINICAL ENDOCRINOLOGY, 2020, 93 (03) : 288 - 295
  • [37] Diagnosis of pheochromocytoma using [123I]-compared with [131I]-metaiodobenzylguanidine scintigraphy
    Furuta, N
    Kiyota, H
    Yoshigoe, F
    Hasegawa, N
    Ohishi, Y
    INTERNATIONAL JOURNAL OF UROLOGY, 1999, 6 (03) : 119 - 124
  • [38] Diagnostic Performance of 68 Ga-DOTATATE PET/CT, 18 F-FDG PET/CT and 131 I-MIBG Scintigraphy in Mapping Metastatic Pheochromocytoma and Paraganglioma
    Tan T.H.
    Hussein Z.
    Saad F.F.A.
    Shuaib I.L.
    Nuclear Medicine and Molecular Imaging, 2015, 49 (2) : 143 - 151
  • [39] Pheochromocytoma - Current Recommendations on Diagnostics, Therapy and Follow-up
    Megerle, Felix
    Fassnacht, Martin
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2017, 142 (24) : 1797 - 1800
  • [40] Dosimetry-based high-activity therapy with 131I-metaiodobenzylguanidine (131I-mIBG) and topotecan for the treatment of high-risk refractory neuroblastoma
    Genolla, Jose
    Rodriguez, Trinidad
    Minguez, Pablo
    Lopez-Almaraz, Ricardo
    Llorens, Veronica
    Echebarria, Aizpea
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (07) : 1567 - 1575
12345